Skip to main content
Log in

Limited Sampling Strategies

  • Correspondence
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Dumont RJ, Ensom MH. Methods for clinical monitoring of cyclosporin in transplant patients. Clin Pharmacokinet 2000; 38: 427–47.

    Article  PubMed  CAS  Google Scholar 

  2. Johnston A, Sketris I, Marsden JT, et al. A limited sampling strategy for the measurement of cyclosporine AUC. Transplant Proc 1990; 22: 1345–6.

    PubMed  CAS  Google Scholar 

  3. Johnston A. Sparse-sampling: a practical method for measurement of AUCs. In: Rashid A, editor. Focus on medicine. Oxford: Blackwell Science Ltd., 1998: 7–10.

    Google Scholar 

  4. David O, Johnston A, Cooney G. Sparse sample measurement of cyclosporin AUC after Neoral® in heart transplant patients [abstract]. Ther Drug Monit 1999; 21: 447.

    Google Scholar 

  5. Gaspari F, Anedda MF, Signorini O, et al. Prediction of cyclosporin area under the curve using a three-point sampling strategy after Neoral administration. J Am Soc Nephrol 1997; 8: 647–52.

    PubMed  CAS  Google Scholar 

  6. Gaspari F, Perico N, Signorini O, et al. Abbreviated kinetic profiles in area-under-the-curve monitoring of cyclosporine therapy. Kidney Int 1998; 54: 2146–50.

    Article  PubMed  CAS  Google Scholar 

  7. Kahan BD, Dunn J, Fitts C, et al. Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals. Transplantation 1995; 59: 505–11.

    PubMed  CAS  Google Scholar 

  8. Keown P, Landsberg D, Halloran P, et al. A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients: report of the Canadian Neoral Renal Transplantation Study Group. Transplantation 1996; 62: 1744–52.

    Article  PubMed  CAS  Google Scholar 

  9. Meier-Kriesche HU, Alloway R, Osama A, et al. Alimited sampling strategy for the estimation of 12-hour SangCya and Neoral AUCs in renal transplant recipients. J Clin Pharmacol 1999; 39: 166–71.

    Article  PubMed  CAS  Google Scholar 

  10. Serafinowicz A, Gaciong Z, Baczkowska T, et al. Limited sampling strategy to estimate exposure to cyclosporine A in renal allograft recipients treated with Sandimmune-Neoral. Transplant Proc 1996; 28: 3138–9.

    PubMed  CAS  Google Scholar 

  11. Serafinowicz A, Gaciong Z, Majchrzak J, et al. Abbreviated kinetic profiles to estimate exposure to CyA in renal allograft recipients treated with Sandimmun-Neoral. Transplant Proc 1997; 29: 277–9.

    Article  PubMed  CAS  Google Scholar 

  12. Holt DW, Johnston A, Kahan BD, et al. New approaches to cyclosporine monitoring raise further concerns about analytical techniques. Clin Chem 2000; 46: 872–4.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

David, O., Johnston, A. Limited Sampling Strategies. Clin Pharmacokinet 39, 311 (2000). https://doi.org/10.2165/00003088-200039040-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-200039040-00006

Keywords

Navigation